Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients

Significance of Tei-index alterations induced by acute preload reduction with hemodialysis

(2011) K. Yakabe et al.   CLINICAL NEPHROLOGY

The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?

(2010) T. E. Larsson   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients

(2009) Heng Jung Hsu et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION

Vitamin D and the Cardiovascular System

(2009) J. N. Artaza et al.   Clinical Journal of the American Society of Nephrology

FGF-23 in dialysis patients: ready for prime time?

(2009) C. Zoccali   NEPHROLOGY DIALYSIS TRANSPLANTATION

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients

(2009) G. Jean et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

As nature did not predict dialysis--what we can learn from FGF23 in end-stage renal disease?

(2009) M. Ketteler et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE